Gansad, Mary Jane .
HRN: 25-30-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/08/2024
07/15/2024
IV
4.5 Grams
Every 8 Hours
Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes